Skip to main content
. Author manuscript; available in PMC: 2018 Nov 12.
Published in final edited form as: J Nucl Med. 2016 Feb;57(Suppl 1):60S–68S. doi: 10.2967/jnumed.115.157917

Table 3.

Imaging Modalities

Modality Signal/contrast Translational Preclinical Sensitivity* Resolution Depth Quantitative Target Acquisition time (s) Cost
PET 11C, 13N, 15O, 18F, 64Cu, 68Ga, 89Zr, 124I Yes Yes 1 1–2 mm No limit Yes (very good) Molecular 10–100 $$$
SPECT 99mTc 123/125I 201Tl
111 In, 177Lu, 67Ga, 133Xe
Yes Yes 10−1-10−2 <1 mm No limit Yes (good) Molecular 100–1,000 $$
MRI Hydrogen, gadolinium, magnetic or paramagnetic particles Yes Yes 10−5 10–100 μm No limit Yes (fair) Anatomic,
molecular
100–1,000 $$$
MR spectroscopy Hyperpolarization (13C, 15N, 129Xe, 3He) Yes Yes <10−5 5 mm No limit Yes (fair) Molecular 100–1,000 $$$
Ultrasound Echoes,
microbubbles
Potential Yes 10−3 50 μm Centimeter Yes (poor) Anatomic,
molecular
<1 $$
Bioluminescence Luciferase (reporter gene) No Yes 1–102* <10 mm Centimeter Yes (poor to fair) Molecular 1–10 $$
Fluorescence Fluorescent proteins, fluorochromes, quantum dots Potential Yes 10−2-1* 2–3 mm <1 cm Yes (poor to fair) Molecular 1–10 $
*

Relative to that of PET.

For high-resolution, small-animal imaging systems (clinical imaging systems differ). Cost is based on purchase price of imaging systems in United States.

$

=low

$$

=intermediate cost

$$$

=high cost.

Depth-dependent